Li J, Gao C, Wang Q, Liu J, Xie Z, Zhao Y
Eur J Neurol. 2024; 31(12):e16493.
PMID: 39324867
PMC: 11554856.
DOI: 10.1111/ene.16493.
Monteiro K, Alcantara M, Aquino T, Silva-Junior E
Curr Neuropharmacol. 2024; 22(7):1169-1188.
PMID: 38708921
PMC: 10964095.
DOI: 10.2174/1570159X22666231016153606.
Linseman D, Winter A, Wilkins H
Biomedicines. 2023; 11(1).
PMID: 36672568
PMC: 9855976.
DOI: 10.3390/biomedicines11010061.
Goldsteins G, Hakosalo V, Jaronen M, Keuters M, Lehtonen S, Koistinaho J
Antioxidants (Basel). 2022; 11(2).
PMID: 35204286
PMC: 8869494.
DOI: 10.3390/antiox11020405.
Mendez-Lopez I, Sancho-Bielsa F, Engel T, Garcia A, Padin J
Int J Mol Sci. 2021; 22(15).
PMID: 34360957
PMC: 8347639.
DOI: 10.3390/ijms22158194.
Intersection between Redox Homeostasis and Autophagy: Valuable Insights into Neurodegeneration.
Park H, Kim J, Shin C, Lee S
Antioxidants (Basel). 2021; 10(5).
PMID: 33924878
PMC: 8146521.
DOI: 10.3390/antiox10050694.
Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases.
Sonninen T, Goldsteins G, Laham-Karam N, Koistinaho J, Lehtonen S
Cells. 2020; 9(10).
PMID: 32998318
PMC: 7601929.
DOI: 10.3390/cells9102183.
The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders.
Tripathi M, Kartawy M, Amal H
Redox Biol. 2020; 34:101567.
PMID: 32464501
PMC: 7256645.
DOI: 10.1016/j.redox.2020.101567.
Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review.
Carrera-Julia S, Moreno M, Barrios C, de la Rubia Orti J, Drehmer E
Front Physiol. 2020; 11:63.
PMID: 32116773
PMC: 7016185.
DOI: 10.3389/fphys.2020.00063.
Amyotrophic Lateral Sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity.
Nakaya T, Maragkakis M
Sci Rep. 2018; 8(1):15575.
PMID: 30349096
PMC: 6197261.
DOI: 10.1038/s41598-018-33964-0.
Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels.
Moller A, Bauer C, Cohen R, Webster C, De Vos K
Hum Mol Genet. 2017; 26(23):4668-4679.
PMID: 28973175
PMC: 5886184.
DOI: 10.1093/hmg/ddx348.
Cellular Chaperones As Therapeutic Targets in ALS to Restore Protein Homeostasis and Improve Cellular Function.
Kalmar B, Greensmith L
Front Mol Neurosci. 2017; 10:251.
PMID: 28943839
PMC: 5596081.
DOI: 10.3389/fnmol.2017.00251.
SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis.
Tafuri F, Ronchi D, Magri F, Comi G, Corti S
Front Cell Neurosci. 2015; 9:336.
PMID: 26379505
PMC: 4548205.
DOI: 10.3389/fncel.2015.00336.
Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis.
Manfredi G, Kawamata H
Neurobiol Dis. 2015; 90:35-42.
PMID: 26282323
PMC: 4754163.
DOI: 10.1016/j.nbd.2015.08.004.
ER stress and unfolded protein response in amyotrophic lateral sclerosis-a controversial role of protein disulphide isomerase.
Jaronen M, Goldsteins G, Koistinaho J
Front Cell Neurosci. 2014; 8:402.
PMID: 25520620
PMC: 4251436.
DOI: 10.3389/fncel.2014.00402.
Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study.
Al-Sarraj S, King A, Cleveland M, Pradat P, Corse A, Rothstein J
Acta Neuropathol Commun. 2014; 2:165.
PMID: 25510661
PMC: 4297389.
DOI: 10.1186/s40478-014-0165-z.
The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis.
Pollari E, Goldsteins G, Bart G, Koistinaho J, Giniatullin R
Front Cell Neurosci. 2014; 8:131.
PMID: 24860432
PMC: 4026683.
DOI: 10.3389/fncel.2014.00131.
Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis.
Vehvilainen P, Koistinaho J, Gundars G
Front Cell Neurosci. 2014; 8:126.
PMID: 24847211
PMC: 4023018.
DOI: 10.3389/fncel.2014.00126.
Spinal but not cortical microglia acquire an atypical phenotype with high VEGF, galectin-3 and osteopontin, and blunted inflammatory responses in ALS rats.
Nikodemova M, Small A, Smith S, Mitchell G, Watters J
Neurobiol Dis. 2013; 69:43-53.
PMID: 24269728
PMC: 4079765.
DOI: 10.1016/j.nbd.2013.11.009.
Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?.
Muyderman H, Chen T
Br J Pharmacol. 2013; 171(8):2191-205.
PMID: 24148000
PMC: 3976630.
DOI: 10.1111/bph.12476.